Related Experiment Video
Updated: Aug 13, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
[Pharmaco-physiologic correlations of iron-dextran complexes in laboratory animals]
Abstract:
Investigated were the Bulgarian preparation dextrofer-100 (Pharmachim) and miofer-100 (Farbwerke, Hoechst, West Germany)--iron-dextran preparations with 100 mg Fe3+/cm3 each. Use was made of 62 domestic cats, 8 guinea pigs, and 18 albino rats. tI was found that the venous introduction of iron-dextran complexes into uretane-treated cats at rates of 100 to 500 mg Fe3+/kg body mass lowered the blood pressure by 10 to 65 per cent; the depressive effect was more strongly manifested with the use of miofer-100. At 100 mg Fe3+/kg and higher doses led to alfa-adrenolytic manifestations (an inverse effect of noradrenaline), and did not change the action of acetyl-choline, histamine, and serotonin. At venous injection the iron-dextran complexes diminished the amplitudes of the heart contractions (with cats in situ). With regard to the nervous-and-muscle condition these preparations were found to manifest an action that resembled that of curare (the effect produced by miofer was stronger). Dextrofer-100 in a five-fold application to guinea pigs at the rate of 0.2 cm3+ (= 20 mg Fe3+) blocked the sensibilizing action of horse serum--it gave protection from an aphylactic shock in about 70 per cent of the animals. In muscular application to albino rats with experimentally induced dextran edema this preparation manifested an antiedema action. The iron-dextran complexes lowered the contraction capacity of ileum sections (taken from guinea pigs) that was manifested under the action of serotonin and histamine.
More Related Videos
Related Concept Videos
Extraction: Advanced Methods
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Toxicity Testing in Animals

